150 related articles for article (PubMed ID: 32338203)
1. A Meta-Analysis of Proteomic Blood Markers of Colorectal Cancer.
Chen X; Sun J; Wang X; Yuan Y; Cai L; Xie Y; Fan Z; Liu K; Jiao X
Curr Med Chem; 2021; 28(6):1176-1196. PubMed ID: 32338203
[TBL] [Abstract][Full Text] [Related]
2. Identification of MST1 as a potential early detection biomarker for colorectal cancer through a proteomic approach.
Yu J; Zhai X; Li X; Zhong C; Guo C; Yang F; Yuan Y; Zheng S
Sci Rep; 2017 Oct; 7(1):14265. PubMed ID: 29079854
[TBL] [Abstract][Full Text] [Related]
3. Advances in Early Detection of Colorectal Cancer: A Focus on Non-invasive Biomarkers.
El Kadmiri N
Curr Drug Targets; 2021; 22(9):1043-1053. PubMed ID: 33655856
[TBL] [Abstract][Full Text] [Related]
4. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
5. Proteomics for early detection of colorectal cancer: recent updates.
Alnabulsi A; Murray GI
Expert Rev Proteomics; 2018 Jan; 15(1):55-63. PubMed ID: 29064727
[TBL] [Abstract][Full Text] [Related]
6. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis.
Villar-Vázquez R; Padilla G; Fernández-Aceñero MJ; Suárez A; Fuente E; Pastor C; Calero M; Barderas R; Casal JI
Proteomics; 2016 Apr; 16(8):1280-90. PubMed ID: 26915739
[TBL] [Abstract][Full Text] [Related]
7. Proteomic screening of potential N-glycoprotein biomarkers for colorectal cancer by TMT labeling combined with LC-MS/MS.
Gong Q; Zhang X; Liang A; Huang S; Tian G; Yuan M; Ke Q; Cai Y; Yan B; Wang J; Wang J
Clin Chim Acta; 2021 Oct; 521():122-130. PubMed ID: 34242638
[TBL] [Abstract][Full Text] [Related]
8. Macrophage mannose receptor 1 and S100A9 were identified as serum diagnostic biomarkers for colorectal cancer through a label-free quantitative proteomic analysis.
Fan NJ; Chen HM; Song W; Zhang ZY; Zhang MD; Feng LY; Gao CF
Cancer Biomark; 2016; 16(2):235-43. PubMed ID: 26682511
[TBL] [Abstract][Full Text] [Related]
9. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
10. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new protein biomarker for colorectal cancer diagnosis.
Zhai XH; Yu JK; Yang FQ; Zheng S
Mol Med Rep; 2012 Aug; 6(2):444-8. PubMed ID: 22614045
[TBL] [Abstract][Full Text] [Related]
12. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
[TBL] [Abstract][Full Text] [Related]
13. Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.
Peltier J; Roperch JP; Audebert S; Borg JP; Camoin L
J Proteomics; 2016 Oct; 148():139-48. PubMed ID: 27492143
[TBL] [Abstract][Full Text] [Related]
14. Circulating Levels of Adipocytokines as Potential Biomarkers for Early Detection of Colorectal Carcinoma in Egyptian Patients.
Zekri AR; Bakr YM; Ezzat MM; Zakaria MS; Elbaz TM
Asian Pac J Cancer Prev; 2015; 16(16):6923-8. PubMed ID: 26514469
[TBL] [Abstract][Full Text] [Related]
15. Improved diagnosis of colorectal cancer using a combination of fecal occult blood and novel fecal protein markers.
Karl J; Wild N; Tacke M; Andres H; Garczarek U; Rollinger W; Zolg W
Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1122-8. PubMed ID: 18928937
[TBL] [Abstract][Full Text] [Related]
16. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
[TBL] [Abstract][Full Text] [Related]
17. A pair-wise meta-analysis highlights circular RNAs as potential biomarkers for colorectal cancer.
Li C; He X; Zhang L; Li L; Zhao W
BMC Cancer; 2019 Oct; 19(1):957. PubMed ID: 31615475
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry based translational proteomics for biomarker discovery and application in colorectal cancer.
Ma H; Chen G; Guo M
Proteomics Clin Appl; 2016 Apr; 10(4):503-15. PubMed ID: 26616366
[TBL] [Abstract][Full Text] [Related]
19. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
[TBL] [Abstract][Full Text] [Related]
20. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study.
Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL
Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]